| 000 | 01370 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250510205932.0 | ||
| 264 | 0 | _c19760213 | |
| 008 | 197602s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(75)92069-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoldman, J M | |
| 245 | 0 | 0 |
_aCombination therapy for advanced resistant Hodgkin's disease. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cDec 1975 |
||
| 300 |
_a1224-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitrosourea Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aRemission, Spontaneous |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 700 | 1 | _aDawson, A A | |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 7947 _gp. 1224-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(75)92069-3 _zAvailable from publisher's website |
| 999 |
_c52634 _d52634 |
||